首页 | 本学科首页   官方微博 | 高级检索  
     

膦甲酸钠治疗重症肝炎疗效观察
引用本文:邱平,贾杰,陈所贤,何远学,许小珍,沈伟. 膦甲酸钠治疗重症肝炎疗效观察[J]. 中国热带医学, 2001, 1(2): 124-125
作者姓名:邱平  贾杰  陈所贤  何远学  许小珍  沈伟
作者单位:海南省人民医院,海口市,570311
基金项目:海南省卫生厅重点资助项目(99-01号)
摘    要:目的 探讨膦甲酸钠治疗重症肝炎的疗效。方法 将1999年12月至2001年1月收治的43例重症肝炎,分为两组,A组为对照组在综合疗法上加用促肝细胞生长素治疗,B组为治疗组在A组疗法上加用膦甲酸钠治疗。结果 A组22例患中治愈1例,好转ll例,无效10例。B组2l例患中治愈ll例,好转7例,无效3例。B组乙肝病毒指标HBeAg阴转率68.7%,HBVDNA阴转率77.7%,而A组均为零。结论 膦甲酸钠对乙肝病毒有确切抑制作用,治疗重症肝炎疗效显。

关 键 词:膦甲酸钠 药物治疗 重症病毒性肝炎 促肝细胞生长素 抗病毒药
文章编号:1009-9727(2001)02-0124-02
修稿时间:2001-05-14

Observation of the therapeutic effects of foscarnet on patients with severe hepatitis
QIU Ping,JIA Jie,CHEN Shuo-xian,et al.. Observation of the therapeutic effects of foscarnet on patients with severe hepatitis[J]. China Tropical Medicine, 2001, 1(2): 124-125
Authors:QIU Ping  JIA Jie  CHEN Shuo-xian  et al.
Abstract:Objective To evaluate the therapeutic effects of foscarnet in severe hepatitis. Methods Forty -three cases of severe hepatitis were divided into Group A and Group B during December 1999 to January 2001. Group A was the control group, which received synthetic treatment and hepatocyte Growth - promoting Factors. Group B was the treatment group, which received group A treatment and foscarnet. Results One of 21 cases in group A was curative,11 cases improved,10 cases inefficient.In group B,11 cases curative,7 casese improved,3 cases inefficient.In group B,68.7%(11/16) HBeAg and 77.7%(14/18)HBVDNA were converted negative,but both in group A were 0% . Conclusions Foscarnet could inhibit HBV replication and had beneficial therapeutic effects on severe hepatitis.
Keywords:Foscarnet  Severe hepatitis  Antivirus.
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号